CCS
MD icon

Crosspoint Capital Strategies’s Pediatrix Medical MD Stock Holding History

Crosspoint Capital Strategies’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-610
Closed -$44K – 635
2015
Q1 		$44K Buy
+610
New +$42.4K 0.02% 275

Other funds holding MD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Crosspoint Capital Strategies's MD Position: Q2 2015 in Review

Crosspoint Capital Strategies sold out of Pediatrix Medical (MD) in Q2 2015, closing a stake of 610 shares — an estimated $44K sold.

Crosspoint Capital Strategies first reported a position in MD in Q1 2015 and held it in 1 quarter. The position peaked at $44K in Q1 2015. 355 funds tracked by Wall St. Rank hold MD as of Q2 2015.

  • Crosspoint Capital Strategies reported no remaining Pediatrix Medical position as of Q2 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 610 Pediatrix Medical shares in Q2 2015, an estimated $44K.
  • Crosspoint Capital Strategies first reported a position in Pediatrix Medical in Q1 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Pediatrix Medical position peaked at $44K in Q1 2015.
  • 355 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2015, filed 24 Aug 2015.